Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia

The soluble urokinase-type plasminogen activator receptor (suPAR) and the urokinase-type plasminogen activator receptor (uPAR) have been proposed as useful biomarkers of tumor progression. Recently, suPAR was associated with chemoresistance in lung cancer. However, its clinical significance in leuke...

Full description

Saved in:
Bibliographic Details
Published in:Oncol Lett
Main Authors: Guo, Hong, Zhou, Lan-Xia, Ma, Haizhen, Liu, Bei, Cheng, Juan, Ma, Yun-Yun, Zhao, Li
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2017
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494859/
https://ncbi.nlm.nih.gov/pubmed/28693180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6150
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items